Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
NCT05380349
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Newly Diagnosed Glioblastoma
Interventions
DRUG:
combinations of up to 3 FDA approved drugs from a panel of compounds
Sponsor
Swedish Medical Center